SEIZERT CAPITAL PARTNERS, LLC

Position in BHC — Bausch Health Companies Inc.

CIK 1134283 BIRMINGHAM, MI

Position in BHC

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$98,910

-$9,376 QoQ

Shares Held

20,063

+0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#143

of 220 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

SEIZERT CAPITAL PARTNERS, LLC holds $94,363,768 across 5 Drug Manufacturers - Specialty & Generic names. BHC ranks #5 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	277,337	$46,742,377
2	UTHR	UNITED THERAPEUTICS Corp	76,828	$41,627,715
3	ZTS	Zoetis Inc.	78,252	$5,623,188
4	PAHC	Phibro Animal Health Corp	8,649	$271,578
5	BHC	Bausch Health Companies Inc. This page	20,063	$98,910

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$98,910	20,063	+0.0%	Shares	Sole	2026-08-05
2026-03-31	$108,286	20,053	—	Shares	Sole	2026-05-07
No filing history on record for this holder in this stock.